Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients-Reference-Cited by-同舟云学术

Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients

Published:2015-12 Issue:3 Volume:139 Page:424-428
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Zhou Rong,Yang Yuan,Lu Qun,Wang Jianliu,Miao Yali,Wang Shijun,Wang Zhiqi,Zhao Chao,Wei Lihui

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Current status of gynecologic cancer in Japan;Ushijima;J. Gynecol. Oncol.,2009

2. Current status in the management of uterine corpus cancer in Korea;Jeong;J. Gynecol. Oncol.,2010

3. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients;Kurman;Cancer,1985

4. Risk factors for young premenopausal women with endometrial cancer;Soliman;Obstet. Gynecol.,2005

5. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer;Papaioannou;Best Pract. Res. Clin. Obstet. Gynaecol.,2010

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Analysis of in vitro Fertilization Outcomes after Fertility-Preserving Therapy for Endometrial Hyperplasia or Carcinoma;Gynecologic and Obstetric Investigation;2024-05-22

2. Metformin for endometrial hyperplasia;Cochrane Database of Systematic Reviews;2024-05-02

3. Metformin and progestins in women with atypical hyperplasia or endometrial cancer: systematic review and meta-analysis;Archives of Gynecology and Obstetrics;2024-03-19

4. Impacts of ovarian reserve on conservative treatment for endometrial cancer and atypical hyperplasia;Frontiers in Endocrinology;2024-01-05

5. The efficacy of the levonorgestrel intrauterine system versus oral megestrol acetate in treating atypical endometrial hyperplasia: a superior randomized controlled trial;Journal of Gynecologic Oncology;2024